CapsoVision, Inc. (CV) vs Standard BioTools Inc. (LAB)
CapsoVision, Inc. and Standard BioTools Inc. are both Medical Devices companies. CapsoVision, Inc. is the larger, with a market value of $328.3M against $291.7M — 1.1× the size. CapsoVision, Inc. trades at the lower P/E: 2.1× against 3.4×. Standard BioTools Inc. grew revenue faster over the last twelve months: 30.2% against 16.7%. Standard BioTools Inc. has the higher net margin (100.4% vs −214.7%) and the higher return on invested capital (−93.9% vs −460.9%). Across the 18 metrics below, Standard BioTools Inc. leads on 10 and CapsoVision, Inc. on 8.
Valuation
Profitability
| Metric | CV | LAB | Medical Devices median |
|---|---|---|---|
| Gross margin | 50.88% | 50.49% | 56.01% |
| Operating margin | (217.09%) | (112.85%) | (15.03%) |
| Net margin | (214.74%) | 100.37% | (20.40%) |
| Free cash flow margin | (200.77%) | (97.61%) | (7.24%) |
| Return on equity | 47.42% | 17.61% | (15.32%) |
| Return on assets | (212.19%) | 14.34% | (19.72%) |
| Return on invested capital | (460.93%) | (93.89%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack